Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.

By J. Weng, Yanbing Li, Wen Xu, Li-xin Shi, Qiao Zhang, Da-long Zhu, Yun Hu, Zhiguang Zhou, Xiang Yan, H. Tian and 13 more. The Lancet, 2008

764 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy (2009, background): “, normoglycemia without need for glucose-lowering medications (87,88).”
Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy (2008, neutral): “normoglycaemia without need for glucoselowering medications [87, 88].”
Canadian Diabetes Association Clinical Practice Guidelines Expert Committee (2013, background): “Although not commonly practiced, the use of intensive insulin therapy (basal-bolus regimen or continuous subcutaneous insulin infusion pump), for a transient period of approximately 2 to 3 weeks at the time of diagnosis or early in the disease course, has been shown to induce diabetes remission, sub”